Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06384352
Status:
RECRUITING
Last Update Posted:
2024-05-10
First Post:
2024-03-26
Brief Title:
A Phase I Study to Evaluate the SafetyTolerability Pharmacokinetics and Efficacy of YL211 in Patients With Advanced Solid Tumors
Sponsor:
Organization:
MediLink Therapeutics Suzhou Co Ltd